Squalene synthase as a target for Chagas disease therapeutics
about
P1343
SQ109, a new drug lead for Chagas disease.Structural and functional analysis of Bacillus subtilis YisP reveals a role of its product in biofilm production.Drug strategies targeting CYP51 in neglected tropical diseasesAryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii.In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.Statins inhibit blastocyst formation by preventing geranylgeranylation.In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan ParasitesDetection and treatment of Trypanosoma cruzi: a patent review (2011-2015).Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites.Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii.Structure, Function, and Inhibition of Staphylococcus aureus Heptaprenyl Diphosphate Synthase.Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat HepatocytesHead-to-Head Prenyl Synthases in Pathogenic Bacteria.Genetic engineering and molecular characterization of yeast strain expressing hybrid human-yeast squalene synthase as a tool for anti-cholesterol drug assessment.
P2860
Q30626912-60246F5D-7264-4200-BB38-8A2CC6671C2EQ34615108-5BA18A49-247F-4125-8694-E69ABB196905Q34622554-8D90235D-F585-485D-960A-286BFADF7382Q35660950-7C6CB075-CB0F-4BDF-9BE7-133D2BF1E946Q35782846-4413BE1F-D997-450C-B122-3D36B9194057Q36075944-9C961BA5-88F7-4442-B60F-17A5F5450309Q36843235-DBA258AE-FB4C-42E8-82B0-7C1B1A6F0F14Q37612993-BC5BE509-67D7-4465-B7F9-A0B54654767FQ38845466-F35D76EA-8744-4A69-9293-18BD3CF27D4FQ38866178-1902F052-D5D9-4BC5-93E2-F2B08426DADBQ38938937-C8E30978-30D6-4518-BE6F-04E3F6A6A3AAQ41025749-07370D23-59BF-45E1-8877-3BE34423C3D8Q41888201-5AB57E83-7280-43AC-9CDE-16E91D660AB2Q50946882-DA34C15D-D853-4D2F-A82B-83936E1809E0Q51565685-8E949622-A79F-4F6C-A236-D21134661920
P2860
Squalene synthase as a target for Chagas disease therapeutics
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Squalene synthase as a target for Chagas disease therapeutics
@ast
Squalene synthase as a target for Chagas disease therapeutics
@en
Squalene synthase as a target for Chagas disease therapeutics
@nl
type
label
Squalene synthase as a target for Chagas disease therapeutics
@ast
Squalene synthase as a target for Chagas disease therapeutics
@en
Squalene synthase as a target for Chagas disease therapeutics
@nl
prefLabel
Squalene synthase as a target for Chagas disease therapeutics
@ast
Squalene synthase as a target for Chagas disease therapeutics
@en
Squalene synthase as a target for Chagas disease therapeutics
@nl
P2093
P2860
P50
P1433
P1476
Squalene synthase as a target for Chagas disease therapeutics
@en
P2093
Carlos A Rodrigues-Poveda
Chun-Chi Chen
Chun-Hsiang Huang
Eric Oldfield
Feifei Ren
Hsiu-Chien Chan
Julio A Urbina
Melina Galizzi
P2860
P304
P356
10.1371/JOURNAL.PPAT.1004114
P407
P577
2014-05-01T00:00:00Z